4.8 Meeting Abstract

HIGH SVR RATES WITH EIGHT AND TWELVE WEEKS OF PANGENOTYPIC GLECAPREVIR/PIBRENTASVIR: INTEGRATED EFFICACY ANALYSIS OF GENOTYPE 1-6 PATIENTS WITHOUT CIRRHOSIS

Journal

GASTROENTEROLOGY
Volume 152, Issue 5, Pages S1059-S1059

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/S0016-5085(17)33577-1

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available